RSS Feed
November 14th, 2020 
Awake Goy 
10 November 2020 — Global Research
The announcement that Pfizer Inc., along with its collaborative partner BioNTech SE, had come up with a successful vaccine candidate to combat the novel coronavirus SARS-CoV-2 sent the markets soaring. In New York, Pfizer’s shares rose by 15 percent in pre-market trading; those of BioNTech, Nasdaq-listed, rose 25 percent. “Today is a great day for science and humanity,” a confident Pfizer Chairman and CEO Albert Bourla crowed. “We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.”
View original post 963 more words
Related posts:
EU Leaders Demand ‘Standardized’ COVID Vaccine Passport
The “Multivalent” Universal mRNA Flu Vaccine & Mandatory Vaccination Bill Passes In British Columbia
TED Talk Goes Viral As He Explains Why He’s Done Trying To Be “Man Enough”
Measles Vaccine Kills 15 Children In South Sudan
Hospital to stop delivering babies as maternity workers resign over vaccine mandate
There is work that just came out in Nature that shows 75% of participants in a Pfizer vaccine trial ...
Posted in 
Tags: 
